Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Sales | 15,195 | 8,250 | 11,396 | 8,873 | 6,616 |
| Cost of Goods | 1,230 | 860 | -493 | 0 | 0 |
| Gross Profit | 13,960 | 7,380 | 11,891 | 8,873 | 6,616 |
| Operating Expenses | 11,750 | 11,250 | 11,373 | 9,201 | 9,733 |
| Operating Income | 2,445 | -3,000 | 23 | -328 | -3,117 |
| Interest Expense | 100 | 120 | 154 | 175 | 197 |
| Other Income | -205 | -700 | 658 | -1,404 | -955 |
| Pre-tax Income | 2,140 | -3,820 | 527 | -1,907 | -4,269 |
| Net Income Continuous | 2,140 | -3,829 | 527 | -1,907 | -4,270 |
| Net Income | $2,140 | $-3,829 | $527 | $-1,907 | $-4,270 |
| EPS Basic Total Ops | 0.07 | -0.12 | 0.02 | -0.06 | -0.16 |
| EPS Basic Continuous Ops | 0.07 | -0.12 | 0.02 | -0.06 | -0.16 |
| EPS Diluted Total Ops | 0.07 | -0.12 | 0.02 | -0.06 | -0.16 |
| EPS Diluted Continuous Ops | 0.07 | -0.12 | 0.02 | -0.06 | -0.16 |
| EBITDA(a) | $3,225 | $-2,140 | $1,076 | $462 | $-1,772 |